Measure of Caregiver Attention-Deficit/Hyperactivity Disorder Knowledge Is Responsive to Decision Aid on Treatment for Attention-Deficit/Hyperactivity Disorder.

Autor: Valentine KD; Department of General Internal Medicine, Massachusetts General Hospital (KD Valentine, H Vo, MJ Barry, B Mancini, and K Sepucha), Boston; Department of Medicine, Harvard Medical School (KD Valentine, MJ Barry, and K Sepucha), Boston, Mass. Electronic address: Kvalentine2@mgh.harvard.edu., Lipstein EA; Department of Pediatrics, Cincinnati Children's Hospital Medical Center (EA Lipstein and WB Brinkman), Cincinnati, Ohio; Department of Pediatrics (EA Lipstein and WB Brinkman), University of Cincinnati College of Medicine, Cincinnati, Ohio., Vo H; Department of General Internal Medicine, Massachusetts General Hospital (KD Valentine, H Vo, MJ Barry, B Mancini, and K Sepucha), Boston., Cosenza C; Center for Survey Research (C Cosenza), University of Massachusetts Boston., Barry MJ; Department of General Internal Medicine, Massachusetts General Hospital (KD Valentine, H Vo, MJ Barry, B Mancini, and K Sepucha), Boston; Department of Medicine, Harvard Medical School (KD Valentine, MJ Barry, and K Sepucha), Boston, Mass., Mancini B; Department of General Internal Medicine, Massachusetts General Hospital (KD Valentine, H Vo, MJ Barry, B Mancini, and K Sepucha), Boston., Brinkman WB; Department of Pediatrics, Cincinnati Children's Hospital Medical Center (EA Lipstein and WB Brinkman), Cincinnati, Ohio; Department of Pediatrics (EA Lipstein and WB Brinkman), University of Cincinnati College of Medicine, Cincinnati, Ohio., Sepucha K; Department of General Internal Medicine, Massachusetts General Hospital (KD Valentine, H Vo, MJ Barry, B Mancini, and K Sepucha), Boston; Department of Medicine, Harvard Medical School (KD Valentine, MJ Barry, and K Sepucha), Boston, Mass.
Jazyk: angličtina
Zdroj: Academic pediatrics [Acad Pediatr] 2024 Apr; Vol. 24 (3), pp. 417-423. Date of Electronic Publication: 2023 Aug 01.
DOI: 10.1016/j.acap.2023.07.016
Abstrakt: Objective: Adapt and test a measure of knowledge for caregivers of children with attention-deficit/hyperactivity disorder (ADHD) and evaluate the impact of the information component of a decision aid (DA) on participant knowledge.
Methods: A set of seven knowledge items were created based on prior knowledge measures and clinical guidelines. As part of a larger cross-sectional survey study of caregivers of children diagnosed with ADHD, caregivers were randomized to one of two arms: 1) a DA arm, where participants reviewed the information component of the Cincinnati Children's Hospital's DA, and 2) a control arm, where participants were not shown a DA. All participants completed the seven knowledge items. Knowledge items were assessed for difficulty, quality of distractors, acceptability, and redundancy. Total knowledge scores (0-100) for the DA and control arm were compared.
Results: Caregivers were assigned to the DA arm (n = 243) or the control arm (n = 260). All 7 knowledge items were retained as no items were too difficult or too easy, all response options were used, there were little missing data, and no items were redundant. The overall knowledge score was normally distributed, and almost covered the full range of scores (5-100). Those who received the DA component had higher knowledge scores (M=68, SD=23) than those who did not receive the DA component (M=60, SD=19, P < .01, d=0.4).
Conclusions: The Caregiver ADHD Knowledge (CAKe) measure was acceptable and demonstrated construct validity as those who were assigned to review the DA component demonstrated greater knowledge than those who were not assigned to review the DA component.
Competing Interests: Declaration of Competing Interest Financial support for this study was provided entirely by a grant from the Agency for Health Research and Quality (grant number R01HSO25718). The funding agreement ensured the authors’ independence in designing the study, interpreting the data, writing, and publishing the report. With regards to potential conflicts of interest for this study. Dr. Lipstein reports previously receiving an institutional grant from Pfizer, Inc. Dr. Brinkman has common stock in the following publicly traded companies: Pfizer, Merck, Abbott Laboratories, Viatris, and Johnson & Johnson. Dr. Sepucha has received consulting income from Blue Cross Blue Shield of Massachusetts. All authors (sans Dr. Brinkman) report support from the Agency for Health Research and Quality.
(Copyright © 2024 Academic Pediatric Association. Published by Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: